198 related articles for article (PubMed ID: 37254438)
1. Investigation of new 1,2,3-triazolyl-quinolinyl-propan-2-ol derivatives as potential antimicrobial agents:
Shinde AD; Nandurkar YM; Bhalekar S; Walunj YS; Ugale S; Ahmad I; Patel H; Chavan AP; Mhaske PC
J Biomol Struct Dyn; 2024; 42(3):1191-1207. PubMed ID: 37254438
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, biological screening and in silico studies of new N-phenyl-4-(1,3-diaryl-1H-pyrazol-4-yl)thiazol-2-amine derivatives as potential antifungal and antitubercular agents.
Nandurkar Y; Bhoye MR; Maliwal D; Pissurlenkar RRS; Chavan A; Katade S; Mhaske PC
Eur J Med Chem; 2023 Oct; 258():115548. PubMed ID: 37307623
[TBL] [Abstract][Full Text] [Related]
3. Discovery of 1,2,3-triazole based quinoxaline-1,4-di-N-oxide derivatives as potential anti-tubercular agents.
Srinivasarao S; Nandikolla A; Suresh A; Ewa AK; Głogowska A; Ghosh B; Kumar BK; Murugesan S; Pulya S; Aggarwal H; Sekhar KVGC
Bioorg Chem; 2020 Jul; 100():103955. PubMed ID: 32464405
[TBL] [Abstract][Full Text] [Related]
4. Novel 1,2,4-oxadiazole-chalcone/oxime hybrids as potential antibacterial DNA gyrase inhibitors: Design, synthesis, ADMET prediction and molecular docking study.
Ibrahim TS; Almalki AJ; Moustafa AH; Allam RM; Abuo-Rahma GEA; El Subbagh HI; Mohamed MFA
Bioorg Chem; 2021 Jun; 111():104885. PubMed ID: 33838559
[TBL] [Abstract][Full Text] [Related]
5. Molecular docking, discovery, synthesis, and pharmacological properties of new 6-substituted-2-(3-phenoxyphenyl)-4-phenyl quinoline derivatives; an approach to developing potent DNA gyrase inhibitors/antibacterial agents.
Alagumuthu M; Arumugam S
Bioorg Med Chem; 2017 Feb; 25(4):1448-1455. PubMed ID: 28094220
[TBL] [Abstract][Full Text] [Related]
6. Structure based design and synthesis of 3-(7-nitro-3-oxo-3,4-dihydroquinoxalin-2-yl)propanehydrazide derivatives as novel bacterial DNA-gyrase inhibitors: In-vitro, In-vivo, In-silico and SAR studies.
Saleh MA; Elmaaty AA; El Saeed HS; Saleh MM; Salah M; Ezz Eldin RR
Bioorg Chem; 2022 Dec; 129():106186. PubMed ID: 36215786
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, antimicrobial activity and molecular modeling study of 3-(5-amino-(2H)-1,2,4-triazol-3-yl]-naphthyridinones as potential DNA-gyrase inhibitors.
Mohamed NG; Sheha MM; Hassan HY; Abdel-Hafez LJM; Omar FA
Bioorg Chem; 2018 Dec; 81():599-611. PubMed ID: 30248511
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and molecular docking of new N4-piperazinyl ciprofloxacin hybrids as antimicrobial DNA gyrase inhibitors.
Mohammed HHH; Ali DME; Badr M; Habib AGK; Mahmoud AM; Farhan SM; Gany SSHAE; Mohamad SA; Hayallah AM; Abbas SH; Abuo-Rahma GEA
Mol Divers; 2023 Aug; 27(4):1751-1765. PubMed ID: 36152132
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, molecular docking, molecular dynamic simulation, and MMGBSA analysis of 7-O-substituted 5-hydroxy flavone derivatives.
Patel KB; Patel RV; Ahmad I; Rajani D; Patel H; Mukherjee S; Kumari P
J Biomol Struct Dyn; 2024 Aug; 42(12):6378-6392. PubMed ID: 37551031
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, biological screening and molecular docking studies of novel multifunctional 1,4-di (aryl/heteroaryl) substituted piperazine derivatives as potential antitubercular and antimicrobial agents.
Mekonnen Sanka B; Mamo Tadesse D; Teju Bedada E; Mengesha ET; Babu G N
Bioorg Chem; 2022 Feb; 119():105568. PubMed ID: 34968884
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, antimicrobial activity and modeling studies of thiazoles bearing pyridyl and triazolyl scaffolds.
Funda Tay N; Berk B; Duran M; Kayagil İ; Yurttaş L; Biltekin Kaleli SN; Yamaç M; Karaduman AB; Demirayak Ş
Z Naturforsch C J Biosci; 2022 Sep; 77(9-10):429-446. PubMed ID: 35472438
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, molecular modeling, and antimicrobial potential of novel 3-[(1H-pyrazol-3-yl)imino]indolin-2-one derivatives as DNA gyrase inhibitors.
Alzahrani AY; Ammar YA; Salem MA; Abu-Elghait M; Ragab A
Arch Pharm (Weinheim); 2022 Jan; 355(1):e2100266. PubMed ID: 34747519
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, computational molecular docking studies of novel heterocyclics bearing 1,2,4-triazole, 1,3,4-oxadiazole conjugates as potent antibacterial and antitubercular agents.
Sravanthi B; Himavathi G; Robert AR; Karunakar P; Kiran KS; Maddila S
J Biomol Struct Dyn; 2024 Jul; 42(10):5376-5389. PubMed ID: 37340639
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, Characterization, and Antimicrobial Activity Screening of Some Novel 3-(2-(3-(Substituted benzyloxy)oxetan-3-yl)-3-fluorophenoxy)-8-fluoro-2-methylquinoline Derivatives as Potential Antimycobacterial Agents.
Shinde A; Ugale SR; Nandurkar Y; Modak M; Chavan AP; Mhaske PC
ACS Omega; 2022 Dec; 7(50):47096-47107. PubMed ID: 36570236
[TBL] [Abstract][Full Text] [Related]
15. Discovery of New Schiff Bases Tethered Pyrazole Moiety: Design, Synthesis, Biological Evaluation, and Molecular Docking Study as Dual Targeting DHFR/DNA Gyrase Inhibitors with Immunomodulatory Activity.
Hassan AS; Askar AA; Naglah AM; Almehizia AA; Ragab A
Molecules; 2020 Jun; 25(11):. PubMed ID: 32498469
[TBL] [Abstract][Full Text] [Related]
16. Molecular modeling and biological investigation of novel s-triazine linked benzothiazole and coumarin hybrids as antimicrobial and antimycobacterial agents.
Zala AR; Kumar D; Razakhan U; Rajani DP; Ahmad I; Patel H; Kumari P
J Biomol Struct Dyn; 2024 Apr; 42(7):3814-3825. PubMed ID: 37218082
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial activity of
Dissanayake DMIH; Perera DDBD; Keerthirathna LR; Heendeniya S; Anderson RJ; Williams DE; Peiris LDC
J Biomol Struct Dyn; 2022 Apr; 40(7):3273-3284. PubMed ID: 33213303
[TBL] [Abstract][Full Text] [Related]
18. Novel anti-tubercular and antibacterial based benzosuberone-thiazole moieties: Synthesis, molecular docking analysis, DNA gyrase supercoiling and ATPase activity.
Omar MA; Masaret GS; Abbas EMH; Abdel-Aziz MM; Harras MF; Farghaly TA
Bioorg Chem; 2020 Nov; 104():104316. PubMed ID: 33022549
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of 2-(6-substituted quinolin-4-yl)-1-alkoxypropan-2-ol as potential antimycobacterial agents.
Shinde A; Thakare PP; Nandurkar Y; Chavan A; Shaikh ALN; Mhaske PC
Chem Zvesti; 2023; 77(7):3791-3802. PubMed ID: 37252671
[TBL] [Abstract][Full Text] [Related]
20. Drug efficacy of novel 3-O-methoxy-4-halo disubstituted 5,7-dimethoxy chromans; evaluated via DNA gyrase inhibition, bacterial cell wall lesion and antibacterial prospective.
Ponnusamy T; Alagumuthu M; Thamaraiselvi S
Bioorg Med Chem; 2018 Jul; 26(12):3438-3452. PubMed ID: 29803359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
